Trials / Unknown
UnknownNCT05992337
New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Cardiology Prague · Network
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Early detection and thus rapid therapy of cardiotoxicity related to chemotherapy are essential for restoring cardiovascular function. The complete recovery of the cardiovascular system decreases with time to identify the presence of cardiotoxic damage. The project aims to define new biomarkers for the early detection of cardiotoxicity in patients treated with chemotherapy.
Detailed description
The most effective approach to minimizing the consequences of cardiotoxicity of oncological treatment is its early identification, adjustment of oncological treatment (change of procedure, dose, drugs), and immediate initiation of cardiovascular therapy. However, the current standard for monitoring the cardiovascular system in cancer patients identifies cardiotoxicity only if functional impairment has already occurred, which precludes any chance of effective prevention. The aim of the project is to identify new biomarkers for the early detection of the cardiotoxic effect of chemotherapy in women with breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood sampling | Blood sample collection for mRNA determination |
| DIAGNOSTIC_TEST | Echocardiography | Echocardiography for detection of ventricular dysfunction |
| DIAGNOSTIC_TEST | Cardio MRI | MRI for early detection of myocardial impairment caused by chemotherapy |
| DIAGNOSTIC_TEST | 24-hours monitoring of ECG | Diagnostic test for detection of arrhythmias as a consequence of cardiotoxicity |
| DIAGNOSTIC_TEST | 24 hours monitoring of BP | Diagnostic test for detection of hypertension as a consequence of cardiotoxicity |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2024-11-01
- Completion
- 2025-01-01
- First posted
- 2023-08-15
- Last updated
- 2023-08-16
Locations
2 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT05992337. Inclusion in this directory is not an endorsement.